Basecamp Research

Basecamp Research (basecamp-research.com) is a private AI-for-science company building “biological foundation models” trained on Basecamp’s proprietary biodiversity data. The company’s thesis is that today’s biological ML is bottlenecked by a “data wall”—narrow, biased datasets—so better models require broader, more diverse, and more provenance-aware biological sequence coverage. Basecamp positions its approach as a full data-to-model pipeline: it assembles BaseData via a large biodiversity sampling network (including access and benefit-sharing arrangements), then trains EDEN, a family of foundation models intended to generate and predict biological candidates across multiple modalities. In its current product messaging, Basecamp emphasizes EDEN-powered discovery use cases including (1) antimicrobial peptide/antibiotic design, (2) antigen immunogenicity prediction, and (3) AI models for programmable gene insertion workflows. Basecamp also highlights downstream “programmable medicines” as an application layer—turning outputs from evolutionary-scale modeling into designs that can be executed in lab/therapeutic R&D. Strategic positioning-wise, the company has recently focused on scaling up its data collection ambition via the Trillion Gene Atlas initiative and on integrating its models into developer workflows through Anthropic’s Claude and through model/capability announcements with NVIDIA-accelerated infrastructure and genomics partners.